Analysis of chlorpyrifos exposure and human health

Expert panel report

James W. Albers, Philip Cole, Raymond S. Greenberg, Jack S. Mandel, Richard R. Monson, John H. Ross, Wayne R. Snodgrass, Anne Spurgeon, Marcia Van Gemert

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

This report summarizes the deliberations of an eight-member panel of scientists convened by Dow AgroSciences in cooperation with the U.S. Environmental Protection Agency (EPA). The panel was charged with evaluating the scientific literature on the health effects potentially associated with exposure to the insecticide chlorpyrifos. Specifically, the panel was asked to (1) evaluate human experience data available and address the adequacy of the available current literature; (2) develop a list of recommendations for epidemiology studies, including appropriate endpoints and study populations, and strengths and weaknesses of each approach; and (3) draft a report to summarize its recommendations. The panel assessed the quality of the existing epidemiologic literature on chlorpyrifos and specific outcomes such as neuropathy (including organophosphate induced delayed neurotoxicity), behavior (cognition and affect), immunologic, and multiple complaints (also referred to as multiple chemical sensitivities). The majority of panel members (five members) agreed that the literature reviewed provided little or no scientific evidence that chlorpyrifos exposure causes harm to human health other than its known cholinergic effects associated with acute poisoning. Those panel members voting in the minority (three members) agreed that the studies reviewed provided inadequate evidence to preclude the possibility of adverse effects to human health from chlorpyrifos exposure at levels associated with its manufacture or professional application. Those voting in the minority suggested further investigation of cohort(s) of workers engaged in either the manufacture or the professional application of chlorpyrifos, or both. Compared to the general population, these groups have relatively high levels of exposure to chlorpyrifos. The primary health outcomes recommended for study were cognitive and affective disorders, with consideration of the assessment of peripheral neuropathy also suggested for at least a subset of the cohort.

Original languageEnglish (US)
Pages (from-to)301-324
Number of pages24
JournalJournal of Toxicology and Environmental Health - Part B: Critical Reviews
Volume2
Issue number4
StatePublished - 1999

Fingerprint

Chlorpyrifos
chlorpyrifos
Health
Politics
Multiple Chemical Sensitivity
Literature
United States Environmental Protection Agency
Epidemiology
Organophosphates
cognition
organophosphate
Environmental Protection Agency
Peripheral Nervous System Diseases
epidemiology
Insecticides
poisoning
Mood Disorders
Population Groups
Poisoning
Cognition

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Public Health, Environmental and Occupational Health
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Albers, J. W., Cole, P., Greenberg, R. S., Mandel, J. S., Monson, R. R., Ross, J. H., ... Van Gemert, M. (1999). Analysis of chlorpyrifos exposure and human health: Expert panel report. Journal of Toxicology and Environmental Health - Part B: Critical Reviews, 2(4), 301-324.

Analysis of chlorpyrifos exposure and human health : Expert panel report. / Albers, James W.; Cole, Philip; Greenberg, Raymond S.; Mandel, Jack S.; Monson, Richard R.; Ross, John H.; Snodgrass, Wayne R.; Spurgeon, Anne; Van Gemert, Marcia.

In: Journal of Toxicology and Environmental Health - Part B: Critical Reviews, Vol. 2, No. 4, 1999, p. 301-324.

Research output: Contribution to journalArticle

Albers, JW, Cole, P, Greenberg, RS, Mandel, JS, Monson, RR, Ross, JH, Snodgrass, WR, Spurgeon, A & Van Gemert, M 1999, 'Analysis of chlorpyrifos exposure and human health: Expert panel report', Journal of Toxicology and Environmental Health - Part B: Critical Reviews, vol. 2, no. 4, pp. 301-324.
Albers, James W. ; Cole, Philip ; Greenberg, Raymond S. ; Mandel, Jack S. ; Monson, Richard R. ; Ross, John H. ; Snodgrass, Wayne R. ; Spurgeon, Anne ; Van Gemert, Marcia. / Analysis of chlorpyrifos exposure and human health : Expert panel report. In: Journal of Toxicology and Environmental Health - Part B: Critical Reviews. 1999 ; Vol. 2, No. 4. pp. 301-324.
@article{44811082616c48ebb666090fd9110112,
title = "Analysis of chlorpyrifos exposure and human health: Expert panel report",
abstract = "This report summarizes the deliberations of an eight-member panel of scientists convened by Dow AgroSciences in cooperation with the U.S. Environmental Protection Agency (EPA). The panel was charged with evaluating the scientific literature on the health effects potentially associated with exposure to the insecticide chlorpyrifos. Specifically, the panel was asked to (1) evaluate human experience data available and address the adequacy of the available current literature; (2) develop a list of recommendations for epidemiology studies, including appropriate endpoints and study populations, and strengths and weaknesses of each approach; and (3) draft a report to summarize its recommendations. The panel assessed the quality of the existing epidemiologic literature on chlorpyrifos and specific outcomes such as neuropathy (including organophosphate induced delayed neurotoxicity), behavior (cognition and affect), immunologic, and multiple complaints (also referred to as multiple chemical sensitivities). The majority of panel members (five members) agreed that the literature reviewed provided little or no scientific evidence that chlorpyrifos exposure causes harm to human health other than its known cholinergic effects associated with acute poisoning. Those panel members voting in the minority (three members) agreed that the studies reviewed provided inadequate evidence to preclude the possibility of adverse effects to human health from chlorpyrifos exposure at levels associated with its manufacture or professional application. Those voting in the minority suggested further investigation of cohort(s) of workers engaged in either the manufacture or the professional application of chlorpyrifos, or both. Compared to the general population, these groups have relatively high levels of exposure to chlorpyrifos. The primary health outcomes recommended for study were cognitive and affective disorders, with consideration of the assessment of peripheral neuropathy also suggested for at least a subset of the cohort.",
author = "Albers, {James W.} and Philip Cole and Greenberg, {Raymond S.} and Mandel, {Jack S.} and Monson, {Richard R.} and Ross, {John H.} and Snodgrass, {Wayne R.} and Anne Spurgeon and {Van Gemert}, Marcia",
year = "1999",
language = "English (US)",
volume = "2",
pages = "301--324",
journal = "Journal of Toxicology and Environmental Health - Part B: Critical Reviews",
issn = "1093-7404",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Analysis of chlorpyrifos exposure and human health

T2 - Expert panel report

AU - Albers, James W.

AU - Cole, Philip

AU - Greenberg, Raymond S.

AU - Mandel, Jack S.

AU - Monson, Richard R.

AU - Ross, John H.

AU - Snodgrass, Wayne R.

AU - Spurgeon, Anne

AU - Van Gemert, Marcia

PY - 1999

Y1 - 1999

N2 - This report summarizes the deliberations of an eight-member panel of scientists convened by Dow AgroSciences in cooperation with the U.S. Environmental Protection Agency (EPA). The panel was charged with evaluating the scientific literature on the health effects potentially associated with exposure to the insecticide chlorpyrifos. Specifically, the panel was asked to (1) evaluate human experience data available and address the adequacy of the available current literature; (2) develop a list of recommendations for epidemiology studies, including appropriate endpoints and study populations, and strengths and weaknesses of each approach; and (3) draft a report to summarize its recommendations. The panel assessed the quality of the existing epidemiologic literature on chlorpyrifos and specific outcomes such as neuropathy (including organophosphate induced delayed neurotoxicity), behavior (cognition and affect), immunologic, and multiple complaints (also referred to as multiple chemical sensitivities). The majority of panel members (five members) agreed that the literature reviewed provided little or no scientific evidence that chlorpyrifos exposure causes harm to human health other than its known cholinergic effects associated with acute poisoning. Those panel members voting in the minority (three members) agreed that the studies reviewed provided inadequate evidence to preclude the possibility of adverse effects to human health from chlorpyrifos exposure at levels associated with its manufacture or professional application. Those voting in the minority suggested further investigation of cohort(s) of workers engaged in either the manufacture or the professional application of chlorpyrifos, or both. Compared to the general population, these groups have relatively high levels of exposure to chlorpyrifos. The primary health outcomes recommended for study were cognitive and affective disorders, with consideration of the assessment of peripheral neuropathy also suggested for at least a subset of the cohort.

AB - This report summarizes the deliberations of an eight-member panel of scientists convened by Dow AgroSciences in cooperation with the U.S. Environmental Protection Agency (EPA). The panel was charged with evaluating the scientific literature on the health effects potentially associated with exposure to the insecticide chlorpyrifos. Specifically, the panel was asked to (1) evaluate human experience data available and address the adequacy of the available current literature; (2) develop a list of recommendations for epidemiology studies, including appropriate endpoints and study populations, and strengths and weaknesses of each approach; and (3) draft a report to summarize its recommendations. The panel assessed the quality of the existing epidemiologic literature on chlorpyrifos and specific outcomes such as neuropathy (including organophosphate induced delayed neurotoxicity), behavior (cognition and affect), immunologic, and multiple complaints (also referred to as multiple chemical sensitivities). The majority of panel members (five members) agreed that the literature reviewed provided little or no scientific evidence that chlorpyrifos exposure causes harm to human health other than its known cholinergic effects associated with acute poisoning. Those panel members voting in the minority (three members) agreed that the studies reviewed provided inadequate evidence to preclude the possibility of adverse effects to human health from chlorpyrifos exposure at levels associated with its manufacture or professional application. Those voting in the minority suggested further investigation of cohort(s) of workers engaged in either the manufacture or the professional application of chlorpyrifos, or both. Compared to the general population, these groups have relatively high levels of exposure to chlorpyrifos. The primary health outcomes recommended for study were cognitive and affective disorders, with consideration of the assessment of peripheral neuropathy also suggested for at least a subset of the cohort.

UR - http://www.scopus.com/inward/record.url?scp=0033392599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033392599&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 301

EP - 324

JO - Journal of Toxicology and Environmental Health - Part B: Critical Reviews

JF - Journal of Toxicology and Environmental Health - Part B: Critical Reviews

SN - 1093-7404

IS - 4

ER -